ArticleBiomedicines2023

Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells.

Christopher D Sarsons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.